Aldeyra Therapeut (ALDX) Misses Q3 EPS by 4c

Aldeyra Therapeut (NASDAQ: ALDX) reported Q3 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Aldeyra Therapeut (ALDX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• Morgan Stanley upgrades CDW on stronger AI-driven server demand